Dermatol. praxi. 2018;12(4):178-181 | DOI: 10.36290/der.2018.042

Impetigo – diagnosis and treatment

MUDr. Táňa Pappová, PhD., MUDr. Andrea Kozárová, PhD.
Dermatovenerologická klinika Jesseniovej lekárskej fakulty v Martine Univerzity Komenského v Bratislave a Univerzitná nemocnica Martin

Impetigo is the most common contagious bacterial infection of the skin affecting mainly children aged between 2 and 5 yearswith the highest incidence in tropical and subtropical climates. Historically, impetigo has been considered a mild skin infection,but in case of insufficient treatment, it can lead to serious clinical disorders. Systemic antibiotics present the first line therapy inwidespread lesions of impetigo. Currently, the increasing prevalence of antibiotic resistance may cause difficulty in managementof impetigo with adverse consequences not only for individuals but also for population.

Keywords: impetigo, streptococcus, staphylococcus, antibiotic resistance

Received: March 26, 2018; Accepted: March 27, 2018; Published: December 1, 2018  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Pappová T, Kozárová A. Impetigo – diagnosis and treatment. Dermatol. praxi. 2018;12(4):178-181. doi: 10.36290/der.2018.042.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Oumeish I, Oumeish OY, Bataineh O. Acute bacterial skin infections in children. Clin Dermatol. 2000; 18(6): 667-78. Go to original source... Go to PubMed...
    2. Chiller K, Selkin BA, Murakawa GJ. Skin microflora and bacterial infections of the skin. J Investig Dermatol Symp Proc. 2001; 6(3): 170-174. Go to original source... Go to PubMed...
    3. Bowen AC, Mahe A, Hay RJ, et al. The global epidemiology of impetigo: a systematic review of the population prevalence of impetigo and pyoderma. PLoS ONE. 2015; 10: e0136789. Go to original source... Go to PubMed...
    4. Lin JN, Chang LL, Lai CH, et al. Clinical and molecular characteristics of invasive and noninvasive skin and soft tissue infections caused by group A streptococcus. J Clin Microbiol. 2011; 49 (10): 3632-3637. Go to original source... Go to PubMed...
    5. Pareira LB. Impetigo - review. An. Bras. Dermatol. 2014; 89 (2): 293-299. Go to original source... Go to PubMed...
    6. Luby SP, Agboatwalla M, Feikin DR, et al. Effect of handwashing on child health: a randomized controlled trial. Lancet. 2005; 366(9481): 225-233. Go to original source... Go to PubMed...
    7. Brown J, Shriner DL, Schwartz RA, Janniger CK. Impetigo: an update. Int J Dermatol. 2003; 42(4): 251-255. Go to original source... Go to PubMed...
    8. Manders SM. Toxin-mediated streptococcal and staphylococcal disease. J Am Acad Dermatol. 1998; 39(3): 383-398. Go to original source... Go to PubMed...
    9. Resnick SD. Pyodermas and Toxin-mediated Syndromes. In: Harper J, Oranche A, Prose N.Textbook of pediatric dermatology, second edition. Blackwell Publishing; 2006: 455-458.
    10. Bangert S, Levy M, Hebert AA. Bacterial resistance and impetigo treatment trends: a review. Pediatr Dermatol. 2012; 29(3): 243-248. Go to original source... Go to PubMed...
    11. Ilyas M, Tolaymat A. Changing epidemiology of acute post-streptococcal glomerulonephritis in Northeast Florida: a comparative study. Pediatr Nephrol. 2008; 23(7): 1101-1106. Go to original source... Go to PubMed...
    12. D'Cunha NM, Peterson GM, Baby KE et Thomas J. Impetigo: A need for new therapies in a world of increasing antimicrobial resistance. Journal of Clinical Pharmacy and Therapeutics 2017; 43(1): 150-153. Go to original source... Go to PubMed...
    13. Christensen OB, Anehus S. Hydrogen peroxide cream: an alternative to topical antibiotics in the treatment of impetigo contagiosa. Acta Derm Venereol. 1994; 74(6): 460-462. Go to original source... Go to PubMed...
    14. Kwieciński J, Eick S, Wójcik K. Effects of tea tree (Melaleuca alternifolia) oil on Staphylococcus aureus in biofilms and stationary growth phase. Int J Antimicrob Agents. 2009; 33 (4):343-347. Go to original source... Go to PubMed...
    15. Magnani L, Mikhail M, Weinberg JM. New antimicrobials. In: Wolf R, Parish LC, Parish JL, eds. Emergency Dermatology, Second Edition. Boca Raton, FL, USA: CRC Press; 2017: 15-32.
    16. Koning S, van der Sande R, Verhagen AP, et al. Interventions for impetigo. Cochrane Database Syst Rev. 2012; 1: CD003261. Go to original source... Go to PubMed...
    17. Cole C, Gazewood J. Diagnosis and treatment of impetigo. Am Fam Physician. 2007; 75(6): 859-864. Go to PubMed...
    18. Bangert S, Levy M, Hebert AA. Bacterial resistance and impetigo treatment trends: a review. Pediatr Dermatol. 2012; 29(3): 243-248. Go to original source... Go to PubMed...
    19. George A, Rubin G. A systematic review and meta-analysis of treatments for impetigo. Br J Gen Pract. 2003; 53(491): 480-487.

    Return to the content


    Dermatology for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.